Evidence of increased circulation of Bordetella pertussis in the Italian adult population from seroprevalence data (2012–2013)

High heterogeneity in methods used for the laboratory confirmation of pertussis diagnosis among European countries, 2010: integration of epidemiological and laboratory surveillance must include standardisation of methodologies and quality assurance

(2017) Q He et al.   Eurosurveillance

Prevalence, diagnosis, and disease course of pertussis in adults with acute cough: a prospective, observational study in primary care

(2015) Jolien Teepe et al.   BRITISH JOURNAL OF GENERAL PRACTICE

T-cell immune responses toBordetella pertussisinfection and vaccination: Graphical Abstract Figure.

(2015) Giorgio Fedele et al.   Pathogens and Disease

Seroprevalence studies of pertussis: what have we learned from different immunized populations

(2015) Alex-Mikael Barkoff et al.   Pathogens and Disease

Epidemiology of pertussis in Italy: Disease trends over the last century

(2014) M V Gonfiantini et al.   Eurosurveillance

Bordetella pertussis pathogenesis: current and future challenges

(2014) Jeffrey A. Melvin et al.   NATURE REVIEWS MICROBIOLOGY

Pertussis re-emergence in the post-vaccination era

(2013) Elena Chiappini et al.   BMC INFECTIOUS DISEASES

The Pertussis Problem

(2013) S. A. Plotkin   CLINICAL INFECTIOUS DISEASES

Bordetella pertussis seroprevalence in Belgian adults aged 20–39 years, 2012

(2013) K. HUYGEN et al.   EPIDEMIOLOGY AND INFECTION

Seroepidemiology of pertussis in a cross-sectional study of an adult general population in Denmark

(2013) P. F. RØNN et al.   EPIDEMIOLOGY AND INFECTION

Attitude of Italian physicians toward pertussis diagnosis

(2013) Michaela Veronika Gonfiantini et al.   Human Vaccines & Immunotherapeutics

Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine

(2012) A. Tomovici et al.   VACCINE

Sources of pertussis infection in young infants: A review of key evidence informing targeting of the cocoon strategy

(2012) K.E. Wiley et al.   VACCINE

Rationale for pertussis booster vaccination throughout life in Europe

(2011) Fred Zepp et al.   LANCET INFECTIOUS DISEASES

What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories

(2010) N. Guiso et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Seroprevalence of Pertussis in the Netherlands: Evidence for Increased Circulation of Bordetella pertussis

(2010) Sabine C. de Greeff et al.   PLoS One

Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination withBordetella pertussisin young children

(2009) HANS O. HALLANDER et al.   APMIS

Seroprevalence of pertussis antitoxin (anti-PT) in Sweden before and 10 years after the introduction of a universal childhood pertussis vaccination program

(2009) HANS O. HALLANDER et al.   APMIS

Characterization of Reference Materials for Human Antiserum to Pertussis Antigens by an International Collaborative Study

(2008) D. Xing et al.   Clinical and Vaccine Immunology

Assessment of humoral and cell-mediated immunity against Bordetella pertussis in adolescent, adult, and senior subjects in Italy

(2008) G. GABUTTI et al.   EPIDEMIOLOGY AND INFECTION

European Sero-Epidemiology Network 2: Standardisation of immunoassay results for pertussis requires homogeneity in the antigenic preparations

(2008) Anna Giammanco et al.   VACCINE

Neonatal Vaccination with an Acellular Pertussis Vaccine Accelerates the Acquisition of Pertussis Antibodies in Infants

(2007) Markus Knuf et al.   JOURNAL OF PEDIATRICS